Announcements Trials
Browse Landscape

Status

Completed 33Withdrawn 6Unknown 2Terminated 2Recruiting 1Active not recruiting 1

Sponsor Class

NIH 4OTHER 2NETWORK 1

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

Leukemia, Myeloid, Acute 1Advanced Breast Cancer 1

Interventions

Cisplatin 349Oxaliplatin 260Capecitabine 258Radiotherapy 238Gemcitabine 221Docetaxel 221Carboplatin 220Drug Therapy 216Cyclophosphamide 216apatinib 200Paclitaxel 199Bevacizumab 194camrelizumab 189Fluorouracil 187sintilimab 131Irinotecan 125Blood Specimen Collection 124Dexamethasone 122Etoposide 118toripalimab 115Surgical Procedures, Operative 115Radiosurgery 114pembrolizumab 111Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 101Surveys and Questionnaires 98tislelizumab 96Doxorubicin 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × In Situ Hybridization, Fluorescence × Clear all
NCT04215822 2020-01-03

PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia

Assiut University

Unknown
80 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00874146 2010-09-02

Level of HER2-neu Gene Amplification an Response to Trastuzumab

Istituto Clinico Humanitas

Unknown
100 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡